/ /

Although surgery is still the gold standard for ocular surface tumors, consider the pros and cons of topical chemotherapy as appropriate.
Use these pearls to better diagnose and treat iris lesions.
When considering premium surgeries and high expectations from patients along with an unrelenting quest for vision exceeding 20/20, the tolerance of residual astigmatism must be zero. Like bespoke tailors, ophthalmologists need to be...
David Karcher, executive director and chief executive officer, The American Society of Cataract and Refractive Surgery (ASCRS), will retire as of December 31, 2018, according to an ASCRS press release. Eric D. Donnenfeld, MD, will...
PRACTICE MANAGEMENT
The underlying, big hairy goal of ...

How long does it actually take to form a new habit? Is there any science to back this up? And what does all of this mean ...

Study sheds light on in-room time ...
Sometimes the answer may simply be a ...
The Retinator II: Judgment Day?
iTECH
Eye banks create the cycle of giving

The Human Tissue “box” that shows up at your hospital or surgery center and its contents go through quite a journey, ...

Top 5 neuro signs never to ignore
How I found my mentors
My refractive surgery journey as ...

Peter McDonnell, MD

Director of The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, and chief medical editor of Ophthalmology Times.

Dianna Graves, COMT, BS Ed

Clinical services manager at St. Paul Eye Clinic PA, Woodbury, MN. Graduate of the School of Ophthalmic Medical Technology, St. Paul, MN, and teaching faculty member since 1983.

Arun C. Gulani, MD

Director of refractive surgery and chief, cornea & external disease. Assistant professor, department of ophthalmology, University of Florida, Jacksonville.

J.C. Noreika, MD, MBA

An ophthalmologist in Medina, OH, discussing trends in ophthalmology, medicine, and healthcare with key leaders in their fields.

Latest Issue

Event Resources

 

Stay current on the latest developments in your specialty with ModernMedicine's regularly updated collection of conference briefs and webinars.


Latest Tweets Follow

Poll

View Results